How to Compare Semaglutide Prices in the UK — and What to Look For

What UK private semaglutide actually costs (and why the range is so wide

A question our prescribers hear most weeks is some version of: "I've seen prices all over the place) what's a normal amount to pay?" It's a fair one. Private semaglutide prices span a wide band, and the variation isn't random. Dose is the biggest driver. The starting dose costs significantly less per pen than the 2.4mg maintenance dose or the newer 7.2mg dose approved by the MHRA in January 2026, so a monthly quote tied to an early dose will look attractive right up until titration. Provider type matters too — a digital-only platform with minimal clinical infrastructure priced its model differently than a GPhC-registered online pharmacy with a full prescribing team. As our semaglutide price guide sets out, market prices for Wegovy typically sit in the £149–£370-per-month range depending on these factors. That's a meaningful spread. Understanding what sits behind each number is the only way to make the comparison real.

Semaglutide for weight management is licensed in the UK as Wegovy, made by Novo Nordisk, and it is a Prescription-Only Medicine under UK law. The NHS medicines page for semaglutide explains the medicine's licensed uses; only Wegovy (not Ozempic, which is the same molecule licensed for type 2 diabetes) is authorised for weight management. That distinction matters when you're assessing what a provider is actually dispensing.

What headline prices often quietly leave out

The number a provider publishes prominently is rarely the total you pay. Several costs are routinely separated out. Consultation fees (sometimes called "assessment fees") are charged upfront before you've even had a prescription written; lose clinical suitability and that fee rarely comes back. Prescription fees are a separate line on some platforms. Delivery is frequently added at checkout, with express options priced on top. Aftercare, meaning clinical access when you have questions or experience a side effect, may exist only as a paid support tier. Dose-change reviews (essential as you titrate from the starting dose upward) can carry their own cost on some models.

When you look at a semaglutide price comparison side by side, add those components mentally before deciding which option is cheaper. A £149 monthly headline with a £25 consultation fee, £10 prescription fee and £7.99 delivery is already £192 before any aftercare. The comparison looks different with those numbers in view. Understanding how semaglutide wholesale pricing works can also help frame why costs differ at the dispensing level.

Where nume sits in the market, and why we're not trying to be cheapest

We're not the most affordable option on a raw price-per-pen comparison, and our semaglutide pen price page explains in detail what that per-pen figure includes and how it compares across dose levels. That's a deliberate position, not an oversight. One transparent price at nume covers the free clinical consultation, the prescription written by a GPhC-registered Independent Prescriber who personally reviews your case the same day, the treatment itself, and free next-working-day tracked delivery by DPD in plain packaging. Priority aftercare runs seven days a week. Every repeat order goes through a full clinical review before we send anything. No subscriptions, no auto-renewals, no hidden line items.

Current treatment pricing is shown on our weight-loss treatments page; we don't print per-pen prices in editorial copy because the clinically right dose for you may not be the one you start on, and we'd rather you know the full picture from a prescriber. You can read more about how our service is structured on our about page, and our clinical team profile shows who leads the prescribing oversight. The GPhC premises registration for our pharmacy is 9012878, verifiable directly at the GPhC pharmacy register.

Why cheapest is the wrong test for a prescription medicine

Price is not a useless signal, wildly below-market pricing is actually a red flag, not a bargain. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold through social media and unverified online sellers. In October 2025, enforcement teams raided a UK site producing fake tirzepatide pens; earlier operations seized around 20 million doses of illegally traded weight-loss medicines. The MHRA Yellow Card scheme allows anyone to report a suspect seller, and the regulator urges buyers to verify any online pharmacy on the GPhC register before purchasing. Sellers offering these medicines without a prescription (or using discount codes to undercut market rates) are operating outside the law.

For a Prescription-Only Medicine, the right question isn't "who charges least?" It's "is this pharmacy registered, is a real clinician reviewing my health before dispensing, and is the supply chain verified?" A small saving at an unverified source carries risks that dwarf the cost difference. Our Wegovy overview covers what legitimate private treatment involves, and our FAQs address common questions about the consultation and prescribing process. If you have a specific concern before starting, our team is reachable via our contact page.